Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is segmented by Devices (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, and Other Devices), Service Providers, and Geography.

Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

APAC Cardiac Arrhythmia Monitoring Devices Market Size

View Global Report
Market Snapshot1
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 1.95 Billion
Market Size (2030) USD 2.89 Billion
CAGR (2025 - 2030) 8.22 %

Major Players

Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

APAC Cardiac Arrhythmia Monitoring Devices Market Analysis

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is estimated at USD 1.95 billion in 2025, and is expected to reach USD 2.89 billion by 2030, at a CAGR of 8.22% during the forecast period (2025-2030).

In most of the cardiac disorders, continuous cardiac monitoring is required. Although cardiac arrhythmia cannot be cured completely, the best possible way to continuously monitor the patients suffering from cardiac arrhythmia is through remote patient monitoring, by using the cardiac arrhythmia monitoring devices, which is referred to as telecardiology.

Japan has the world's fastest ageing population. According to the World Ageing 2019 report, estimates the number of the population who are above 65 years of age in Japan was 35.524 million (28%) in 2019 which is projected to reach 37.278 million (30.9%) in 2030. As the number of geriatric population is expected to increase in the coming years who are more prone to chronic diseases such as cardiovascular diseases which ultimately rises the growth of the market as this group population need monitoring of the heart which ultimately increases the use of monitoring devices in near future.

The rising incidence of heart diseases in Asia-Pacific is also influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market studied in the future.

APAC Cardiac Arrhythmia Monitoring Devices Industry Overview

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is consolidated competitive with few major players. Market players with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness which has also helped the market grow.

APAC Cardiac Arrhythmia Monitoring Devices Market Leaders

  1. Abbott Laboratories Inc

  2. Biotronik

  3. Medtronic PLC

  4. GE Healthcare

  5. Koninklijke Philips NV

  6. *Disclaimer: Major Players sorted in no particular order
APAC cardiac landscape.png
Need More Details on Market Players and Competiters?
Download PDF

APAC Cardiac Arrhythmia Monitoring Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Use of Telecardiology
    • 4.2.2 Development of Smart Cardiac Monitors
    • 4.2.3 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Remote Cardiac Arrhythmia Monitoring
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Device
    • 5.1.1 Event Monitoring Devices
    • 5.1.2 Continuous Rhythm Monitoring Devices
    • 5.1.3 Holter Monitoring Devices
    • 5.1.4 Other Devices
  • 5.2 By Service Provider
    • 5.2.1 Mobile Cardiac Telemetry Monitoring Service Providers
    • 5.2.2 Independent Diagnostic Testing Facilities/Clinics
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
    • 5.3.1.1 China
    • 5.3.1.2 Japan
    • 5.3.1.3 India
    • 5.3.1.4 Australia
    • 5.3.1.5 South Korea
    • 5.3.1.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biotronik
    • 6.1.3 GE Healthcare
    • 6.1.4 Medtronic PLC
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 AliveCor Inc
    • 6.1.7 iRhythm Technologies Inc
    • 6.1.8 Medi-Lynx
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

APAC Cardiac Arrhythmia Monitoring Devices Industry Segmentation

As per the scope of the report, Cardiac arrhythmia monitoring devices are used for monitoring the patients at risk or with heart arrhythmia. These devices detect and alarm the heartbeats that are irregular being either too slow or too fast. The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market is segmented by devices, service provider, and geography.

By Device Event Monitoring Devices
Continuous Rhythm Monitoring Devices
Holter Monitoring Devices
Other Devices
By Service Provider Mobile Cardiac Telemetry Monitoring Service Providers
Independent Diagnostic Testing Facilities/Clinics
Geography Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

APAC Cardiac Arrhythmia Monitoring Devices Market Research FAQs

How big is the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market?

The Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 1.95 billion in 2025 and grow at a CAGR of 8.22% to reach USD 2.89 billion by 2030.

What is the current Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size?

In 2025, the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size is expected to reach USD 1.95 billion.

Who are the key players in Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market?

Abbott Laboratories Inc, Biotronik, Medtronic PLC, GE Healthcare and Koninklijke Philips NV are the major companies operating in the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market.

What years does this Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market cover, and what was the market size in 2024?

In 2024, the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size was estimated at USD 1.79 billion. The report covers the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Cardiac Arrhythmia Monitoring Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Cardiac Arrhythmia Monitoring Devices Industry Report

Statistics for the 2025 Asia-Pacific Cardiac Arrhythmia Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Cardiac Arrhythmia Monitoring Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.